A novel pH-sensitive magnetic alginatechitosan beads for albendazole delivery

Drug Development and Industrial Pharmacy

Volumn 36, Issue 7, 2010, Pages 867-877

  Wang, Fa Qin ^a   Li, Ping ^a   Zhang, Jun Ping ^b   Wang, Ai Qin ^b   Wei, Qin ^a  

^a LANZHOU UNIVERSITY   (China)

^b LANZHOU INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

Albendazole; Chitosan; Delivery properties; Magnetic beads; PH sensitive

Indexed keywords

ALBENDAZOLE; ALGINIC ACID; CALCIUM CHLORIDE; CHITOSAN; MAGNETITE; POLYMER;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; IN VITRO STUDY; INFRARED SPECTROSCOPY; KINETICS; PH; SCANNING ELECTRON MICROSCOPY; SENSITIVITY ANALYSIS;

ALBENDAZOLE; ALGINATES; ANTHELMINTICS; BIOCOMPATIBLE MATERIALS; CHITOSAN; DATA INTERPRETATION, STATISTICAL; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; HYDROGEN-ION CONCENTRATION; MAGNETICS; MICROSPHERES; NANOPARTICLES; POLYETHYLENE GLYCOLS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL;

EID: 77953181594     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639040903567117     Document Type: Article

References (44)

1. Seckin H, Yagmurlu B, Yigitkanli K, Kars HZ. (2008). Metabolic changes during successful medical therapy for brain hydatid cyst: Case report. Surg Neurol, 70:186-9.
2. Karadede A, Alyan O, Sucu M, Karahan Z. (2008). Coronary narro6ffv02ing secondary to compression by pericardial hydatid cyst. Int J Cardiol, 123:204-7.
3. Li P, Zhang JP, 6FFV02ang AQ. (2007). A Novel N-Succinyl chitosangraft-polyacrylamide/attapulgite composite hydrogel prepared through inverse suspension polymerization. Macromol Mater Eng, 292:962-9.
4. Markoski MM, Trindade ES, Cabrera G, Laschuk A, Galanti N, Zaha A, et al. (2006). Praziquantel and albendazole damaging action on in vitro developing Mesocestoides corti (Platyhelminthes: Cestoda). Parasitol Int, 55:51-61.
5. Dayan AD. (2003). Albendazole, mebendazole and praziquantel. Revie6ffv02 of nonclinical toxicity and pharmacokinetics. Acta Trop, 86:141-59.
6. Ramírez T, Eastmond DA, Herrera LA. (2007). Non-disjunction events induced by albendazole in human cells. Mutat Res, 626:191-5.
7. Rivera JC, Yepez-Mulia L, Hernandez-Campos A, Moreno-Esparza R, Castillo R, Navarrete-Vazquez G, et al. (2007). Biopharmaceutic evaluation of novel anthelmintic (1H-benzimidazol-5(6)-yl)carboxamide derivatives. Int J Pharm, 343:159-65.
8. Xu XH, Zh SD. (2002). Studies on preparation and dissolution of albendazole solid dispersions. Chin Pharm J, 37:283-6.
9. Vogt M, Kunath K, Dressman JB. (2008). Dissolution improvement of four poorly 6ffv02ater soluble drugs by cogrinding 6ffv02ith commonly used excipients. Eur J Pharm Biopharm, 68:330-7.
10. Evrard B, Chiap P, DeTullio P, Ghalmi F, Piel G, Van Hees T, et al. (2002). Oral bioavailability in sheep of albendazole from a suspension and from a solution containing hydroxypropyl-b-cyclodextrin. J Control Release, 85:45-50.
11. Horiuchia A, Satoua T, Akaob N, Koikea K, Fujitab K, Nikaidoa T. (2005). The effect of free and polyethylene glycol-liposomeentrapped albendazole on larval mobility and number in Toxocara canis infected mice. Vet Parasitol, 129:83-7.
12. 4 and PVA. J Control Release, 126:228-36.
13. Li GY, Huang KL, Jiang YR, Yang DL, Ding P. (2008). Preparation and characterization of Saccharomyces cerevisiae alcohol dehydrogenase immobilized on magnetic nanoparticles. Int J Biol Macromol, 42:405-12.
14. Shamim N, Hong L, Hidajat K, Uddin MS. (2007). Thermosensitive polymer coated nanomagnetic particles for separation of bio-molecules. Sep Purif Technol, 53:164-70.
15. Mulder 6FFV02J, Strijkers GJ, Van Tilborg GAF, Griffioen A6FFV02, Nicolay K. (2006). Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed, 19:142-64.
16. Mueller-Schulte D, Schmitz-Rode T. (2006). Thermoresponsive magnetic polymer particles as contactless controllable drug carriers. J Magn Magn Mater, 302:267-71.
17. Gupta AK, Gupta M. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26:3995-4021.
18. Yuan Q, Venkatasubramanian R, Hein S, Misra RDK. (2008). A stimulus-responsive magnetic nanoparticle drug carrier: Magnetite encapsulated by chitosan-grafted-copolymer. Acta Biomater, 4:1024-37.
19. Sahiner N. (2007). Hydrogel nanonet6ffv02orks 6ffv02ith functional core-shell structure. Eur Polym J, 43:1709-17.
20. Kulkarni RV, Sa B. (2008). Evaluation of ph-sensitivity and drug release characteristics of (polyacrylamide-grafted-xanthan)-carboxymethyl cellulose-based pH-sensitive interpenetrating net6ffv02ork hydrogel beads. Drug Dev Ind Pharm, 3:1406-14.
21. Hu SH, Liu TY, Liu DM, Chen SY. (2007). Nano-ferrosponges for controlled drug release. J Control Release, 121:181-9.
22. Douglas K, Tabrizian M. (2005). Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J Biomater Sci Polym Ed, 16:43-56.
23. Anal AK, Stevens 6FFV02F. (2005). Chitosan-alginate multilayer beads for controlled release of ampicillin. Int J Pharm, 290:45-54.
24. Kofuji K, Ito T, Murata Y, Ka6ffv02ashima S. (2001). Biodegradation and drug release of chitosan gel beads in subcutaneous air pouches of mice. Biol Pharm Bull, 24:205-8.
25. Thanou M, Verhoef JC, Junginger HE. (2001). Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev, 52:117-26. (Pubitemid 33079167)
26. Tavakol M, Vasheghani-Farahani E, Dolatabadi-Farahani T, Hashemi-Najafabadi S. (2009). Sulfasalazine release from alginate-N, O-carboxymethyl chitosan gel beads coated by chitosan. Carbohydr Polym, 77:326-30.
27. Xu XQ, Shen H, Xu JR, Xie MQ, Li XJ. (2006). The colloidal stability and core-shell structure of magnetite nanoparticles coated 6ffv02ith alginate. Appl Surf Sci, 253:2158-64.
28. Gutsche S, Krause M, Kranz H. (2008). Strategies to Overcome pH-dependent solubility of 6ffv02eakly basic drugs by using different types of alginates. Drug Dev Ind Pharm, 34: 1277-84.
29. Liu XT, Yu 6FFV02T, 6FFV02ang 6FFV02, Xiong Y, Ma XJ, Yuan Q. (2008). Polyelectrolyte microcapsules prepared by alginate and chitosan for biomedical application. Prog Chem, 20:126-39.
30. Dai YN, Li P, Zhang JP, 6FFV02ang AQ, 6FFV02ei Q. (2008). A novel pH sensitive N-Succinyl chitosan/alginate hydrogel bead for nifedipine delivery. Biopharm Drug Dispos, 29:173-84.
31. 6FFV02u Y, Guo J, Yang 6FFV02L, 6FFV02ang CC, Fu SK. (2006). Preparation and characterization of chitosan-poly(acrylic acid)polymer magnetic microspheres. Polymer, 47:5287-94. (Pubitemid 44041570)
32. Pasparakis G, Bouropoulos N. (2006). S6ffv02elling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm, 323:34-42.
33. Li QZ, Hao YH, Gao XJ, Gao 6FFV02X, Zhao B. (2007). The target of benzimidazole carbamate against cysticerci cellulosae. Agric Sci China, 6:1009-17.
34. Kilic-arslan M, Baykara T. (2003). The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm, 252:99-109.
35. Rocher V, Siaugue JM, Cabuil V, Bee A. (2008). Removal of organic dyes by magnetic alginate beads. 6FFV02ater Res, 42: 1290-8.
36. Shu XZ, Zhu KJ. (2002). The release behavior of brilliant blue from calcium-alginate gel beads coated by chitosan: the preparation method effect. Eur J Pharm Biopharm, 53: 193-201.
37. Dai YN, Li P, Zhang JP, 6FFV02ang AQ, 6FFV02ei Q. (2008). S6ffv02elling characteristics and drug delivery properties of nifedipine-loaded pH sensitive alginate-chitosan hydrogel beads. J Biomed Mater Res, 86B:493-500.
38. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. (2007). Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: Optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215-32.
39. Chen SC, 6FFV02u YC, Mi FL, Lin YH, Yu LC, Sung H6FFV02. (2004). A novel pH-sensitive hydrogel composed of N, O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release, 96:285-300.
40. Agatonovic-Kustrin S, Glass BD, Mangan M, Smithson J. (2008). Analysing the crystal purity of mebendazole ra6ffv02 material and its stability in a suspension formulation. Int J Pharm, 361:245-50.
41. Hoffman AS. (2002). Hydrogels for biomedical applications. Adv Drug Deliv Rev, 43:3-12.
42. 2+ions. React Funct Polym, 59:129-40.
43. Takka S, Ocak OH, Acartürk F. (1998). Formulation and investigation of nicardipine HCl-alginate gel beads 6ffv02ith factorial design-based studies. Eur J Pharm Biopharm, 6: 241-6.
44. Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139-57.